Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-26 · accession 0001213900-26-008221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 | 2026-01-26 | TARA | Fabbio Patrick | CFO | F - Tax | $6.67 | -3,261 | 64.1K | -5% | -$21.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-26 | F | D | 3,261 | $6.67 | 64,115 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025. |